EYPT - EyePoint Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts4443
Avg. Estimate-0.1-0.07-0.330.12
Low Estimate-0.12-0.09-0.38-0.1
High Estimate-0.09-0.05-0.260.48
Year Ago EPS-0.11-0.15-0.54-0.33
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts4444
Avg. Estimate3.73M7.47M30.53M92.63M
Low Estimate2.61M5.66M21.58M54.58M
High Estimate5.6M10.3M41.4M155M
Year Ago Sales6.69M2.51M20.36M30.53M
Sales Growth (year/est)-44.20%197.70%49.90%203.40%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.12-0.14-0.12-0.1
EPS Actual-0.11-0.15-0.1-0.11
Difference0.01-0.010.02-0.01
Surprise %8.30%-7.10%16.70%-10.00%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.1-0.07-0.330.12
7 Days Ago-0.1-0.07-0.330.12
30 Days Ago-0.1-0.07-0.330.12
60 Days Ago-0.11-0.08-0.320.1
90 Days Ago-0.11-0.08-0.320.1
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesEYPTIndustrySector(s)S&P 500
Current Qtr.9.10%N/AN/AN/A
Next Qtr.53.30%N/AN/AN/A
Current Year38.90%N/AN/AN/A
Next Year136.40%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A